WEKO3
アイテム
Current Management of Chronic Kidney Disease in the Elderly Patients
https://dmu.repo.nii.ac.jp/records/2000005
https://dmu.repo.nii.ac.jp/records/2000005076f4202-7ee7-47f1-938e-fde890dfe6f1
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
DKMJ-2-1-1.pdf (85 KB)
|
.png)
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||||
|---|---|---|---|---|---|---|---|---|
| タイトル | ||||||||
| タイトル | Current Management of Chronic Kidney Disease in the Elderly Patients | |||||||
| 言語 | en | |||||||
| 言語 | ||||||||
| 言語 | eng | |||||||
| キーワード | ||||||||
| 言語 | en | |||||||
| 主題Scheme | Other | |||||||
| 主題 | chronic kidney disease | |||||||
| キーワード | ||||||||
| 言語 | en | |||||||
| 主題Scheme | Other | |||||||
| 主題 | CKD | |||||||
| キーワード | ||||||||
| 言語 | en | |||||||
| 主題Scheme | Other | |||||||
| 主題 | elderly | |||||||
| キーワード | ||||||||
| 言語 | en | |||||||
| 主題Scheme | Other | |||||||
| 主題 | GFR | |||||||
| 資源タイプ | ||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||
| 資源タイプ | journal article | |||||||
| 著者 |
Tanaka, Tetsuro
× Tanaka, Tetsuro
|
|||||||
| 書誌情報 |
Dokkyo Medical Journal 巻 2, 号 1, p. 1-6, 発行日 2023-03-25 |
|||||||
| 記事種別 | ||||||||
| Review Article | ||||||||
| 内容記述 | ||||||||
| 内容記述タイプ | Abstract | |||||||
| 内容記述 | The number of elderly people aged 65 and over is increasing all over the world. In parallel, the number of elderly patients with chronic kidney disease (CKD) is also increasing, especially in the advanced stages. Clinical trials that evaluate treatment for CKD usually exclude patients over the age of 80. Therefore, it is difficult to apply the current treatments recommended for younger CKD patients to the elderly. It is really necessary to include the elderly in CKD clinical trials in the future so that we can generate evidence-based therapies for this group. In addition, new therapies for treating and slowing the progression of CKD are needed for all age groups. CKD is a very common clinical problem in older patients and is associated with increased morbidity and mortality. As life expectancy continues to improve around the world, there is a rising prevalence of comorbidities and risk factors such as hypertension, diabetes, and dyslipidemia predisposing to a high burden of CKD in the elderly. Thus, this review seeks to explore the epidemiology of CKD and discuss the current management of CKD in the elderly. We have outlined the key points of CKD treatment, but unfortunately, there are few studies on outcomes specific to elderly CKD patients. | |||||||
| 言語 | en | |||||||
| 出版者 | ||||||||
| 出版者 | Dokkyo Medical Society | |||||||
| ISSN | ||||||||
| 収録物識別子タイプ | EISSN | |||||||
| 収録物識別子 | 2436-522X | |||||||
| DOI | ||||||||
| 関連タイプ | isIdenticalTo | |||||||
| 識別子タイプ | DOI | |||||||
| 関連識別子 | https://doi.org/10.51040/dkmj.2022-024 | |||||||
| 出版タイプ | ||||||||
| 出版タイプ | VoR | |||||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||
